Effects of empagliflozin on liver fat in patients with metabolic dysfunction-associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial - Cheung, Ka Shing; Ng, Ho Yu; Hui, Rex Wan Hin; Lam, Lok Ka; Mak, Lung Yi; Ho, Yuen Chi; Tan, Jing Tong; Chan, Esther W.; Seto, Wai Kay; Yuen, Man Fung; Leung, Wai K. (Hepatology (Baltimore, Md.), 2024)
Keywords: Adult; Aged; Benzhydryl Compounds - therapeutic use; Double-Blind Method; Female; Glucosides - therapeutic use; Humans; Liver - diagnostic imaging; Liver - drug effects; Liver - pathology; Magnetic Resonance Imaging; Male; Middle Aged; Non-alcoholic Fatty Liver Disease - complications; Non-alcoholic Fatty Liver Disease - diagnostic imaging; Non-alcoholic Fatty Liver Disease - drug therapy; Sodium-Glucose Transporter 2 Inhibitors - therapeutic use; Treatment Outcome